BLUE-C: Next Generation Multi-Target Stool DNA Test for Colorectal Cancer and Advanced Neoplasia
As clinicians work to improve CRC screening rates, a promising new test has shown favorable accuracy in detecting cases.
Source: hcplive.com
Generation Multitarget Stool News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Generation Multitarget Stool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Generation Multitarget Stool Today - Breaking & Trending Today
The NEJM publishes Cologuard Plus test results
Cologuard Plus was evaluated against an independent fecal immunochemical test ,which it significantly outperformed.
Source: selectscience.net
The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study
13.03.2024 - Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, 'Next-Generation ... Seite 1
Source: wallstreet-online.de
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included...
Source: marketscreener.com